The American Society of Clinical Oncology published an update expanding the utility of Breast Cancer Index, developed by Hologic Inc., within its Clinical Practice Guideline, “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”
Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level.
